semaglutide news november 28 2025 Real-World Weight Loss Observed With and Tirzepatide in Patients with Overweight or Obesity and Without Type 2 Diabetes (SHAPE) | Advances in Therapy Drugmakers are racing to find

The pathology of vascular dementia: a critical update

Exploring the Potential of Supplements for Adult ADHD: A Comprehensive Guide A Holistic Approach to ADHD Management Managing Adult Attention Deficit Hyperactivity Disorder (ADHD) is a multifaceted journey

Understanding Semaglutide's Role in Weight Management Semaglutide is central in Searcy's weight loss strategies as a GLP-1 receptor agonist for overweight and obesity in adults

The most common serious laboratory abnormalities (grade 3 or 4, 2%) were leukopenia, anemia, decreased phosphate, hypocalcemia, hyponatremia, increased liver enzymes, thrombocytopenia, and increased alkaline phosphatase levels (NCT03037385) [36,37]